Puma Biotechnology, Inc. , a biopharmaceutical company, announced that it has been added to the Nasdaq Biotechnology Index , effective at the close of trading on Friday, December 19, 2025. "Our ...
Lunsumio VELO reduces administration time from 2-4 hours to approximately one minute –– Availability of Lunsumio VELO allows ...
CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the two pivotal Phase 3 randomized, ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation ...
Major changes are being made to Medicare in 2026 now that Medicare.gov will be using ID.me and CLEAR to verify beneficiaries ...
Abxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") , today announced that the U.S. Food and Drug ...
CareDx, Inc. reports its first net profit in a decade with improved cash flow and margins. Click for this updated look at CDNA stock prospects.